ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Margin Recommendations for Cutaneous Malignancies in Immunocompetent and Immunocompromised Patients

by Jessa E. Miller, MD, Kristen A. Echanique, MD, and Maie A. St. John, MD, PhD • October 19, 2021

  • Tweet
  • Email
Print-Friendly Version

TRIO Best PracticeTRIO Best Practice articles are brief, structured reviews designed to provide the busy clinician with a handy outline and reference for day-to-day clinical decision making. The ENTtoday summaries below include the Background and Best Practice sections of the original article. To view the complete Laryngoscope article, visit Laryngoscope.

You Might Also Like

No related posts.

Explore This Issue
October 2021

BACKGROUND

Non-melanoma skin cancer (NMSC) is the most prevalent type of malignancy worldwide, with more than 1 million cases of NMSC diagnosed in the United States each year. The most common types of NMSC are basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC). Numerous risk factors exist for NMSC, including ultraviolet radiation, ionizing radiation, genetic disorders, chronic inflammation, and immunosuppression.

Compared with the general population, patients who are chronically immunosuppressed have a significantly increased risk of developing NMSC; organ transplant recipients are 65 to 250 times more likely to develop cSCC and 10 to 16 times more likely to develop BCC. In immunosuppressed patients, prevention strategies, frequent surveillance, and early intervention are critical for reducing the morbidity and mortality associated with NMSC.

When treating patients with NMSC, it is important to determine if they are at low risk or high risk for recurrence, as this has important prognostic implications and affects their recommended treatment algorithm. Several characteristics including lesion size, location, borders, histopathologic features, and patient history of prior radiation therapy or immunocompromised state factor into the determination of whether a patient is at low risk or high risk. Based on the 2021 National Comprehensive Cancer Network guidelines (see Figure 1), all patients who are immunosuppressed should be classified as having high-risk lesions.

BEST PRACTICE

Several factors, such as tumor size, location, and histopathological features, must be considered when deciding on surgical margins for NMSC. For low-risk cSCC, 4 to 6 mm margins are recommended, whereas for low-risk BCC, the recommendation is for 4 mm margins. Per the NCCN guidelines, chronic immunosuppression places patients with cSCC and BCC into the high-risk category. For patients with high-risk cSCC and BCC, the standard of care is complete circumferential peripheral and deep margin assessment; however, if this is not possible, then standard surgical excision with 4 to 6 mm and 4 mm margins, respectively, is recommended

Figure 1. Management of NMSC based on the National Comprehensive Cancer Network guidelines. BCC = basal cell carcinoma; CCPDMA = complete circumferential peripheral and deep margin assessment; cSCC = cutaneous squamous cell carcinoma; NMSC = nonmelanoma skin cancer.

Figure 1. Management of NMSC based on the National Comprehensive Cancer Network guidelines. BCC = basal cell carcinoma; CCPDMA = complete circumferential peripheral and deep margin assessment; cSCC = cutaneous squamous cell carcinoma; NMSC = nonmelanoma skin cancer.

Pages: 1 2 | Single Page

Filed Under: Head and Neck, Head and Neck, TRIO Best Practices Tagged With: skin cancer, treatmentIssue: October 2021

You Might Also Like:

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Complications for When Physicians Change a Maiden Name
    • Neurogenic Cough Is Often a Diagnosis of Exclusion
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • FDA Approves First Treatment for Eosinophilic Esophagitis
    • Clinical Best Practices: Otolaryngologists Tackle Questions
    • Otolaryngologist Shares Experience with Image Manipulation in Research and How to Prevent It
    • Methodology to Study Care Barriers for Head and Neck Cancer Patients in Low- and Middle-Income Countries Yields Insights
    • Spreader Graft Placement Found Comparable in Functional Outcome in Patients with Nasal Obstruction

Polls

Do you think most image manipulation in studies is done accidentally or on purpose?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2022 The Triological Society. All Rights Reserved.
ISSN 1559-4939